187 related articles for article (PubMed ID: 23782334)
21. Some observations on pyloric gland adenoma: an uncommon and long ignored entity!
Vieth M; Montgomery EA
J Clin Pathol; 2014 Oct; 67(10):883-90. PubMed ID: 25092673
[TBL] [Abstract][Full Text] [Related]
22. Altered gastric chief cell lineage differentiation in histamine-deficient mice.
Nozaki K; Weis V; Wang TC; Falus A; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1211-20. PubMed ID: 19359424
[TBL] [Abstract][Full Text] [Related]
23. Gastric adenocarcinoma with chief cell differentiation.
Tsukamoto T; Yokoi T; Maruta S; Kitamura M; Yamamoto T; Ban H; Tatematsu M
Pathol Int; 2007 Aug; 57(8):517-22. PubMed ID: 17610477
[TBL] [Abstract][Full Text] [Related]
24. Duodenal adenocarcinoma arising from a pyloric gland adenoma with a brief review of the literature.
Khor TS; Brown I; Kattampallil J; Yusoff I; Kumarasinghe MP
BMJ Case Rep; 2010 Dec; 2010():. PubMed ID: 22802482
[TBL] [Abstract][Full Text] [Related]
25. An LCM-based genomic analysis of SPEM, Gastric Cancer and Pyloric Gland Adenoma in an Asian cohort.
Srivastava S; Huang KK; Rebbani K; Das K; Fazreen Z; Yeoh KG; Tan P; Teh M
Mod Pathol; 2020 Oct; 33(10):2075-2086. PubMed ID: 32269290
[TBL] [Abstract][Full Text] [Related]
26. A case of pyloric gland adenoma with high-grade dysplasia in the duodenum arising from heterotopic gastric mucosa observed over 5 years.
Kitagawa D; Yamasaki T; Ikeda T; Sakata Y; Hirata N; Suekane T; Sugimori S; Ishii N; Sakurai K; Nebiki H
Clin J Gastroenterol; 2023 Feb; 16(1):26-31. PubMed ID: 36306058
[TBL] [Abstract][Full Text] [Related]
27. [Tubular adenoma of the stomach with special reference to the Japanese criteria and pyloric gland adenoma].
Kushima R; Vieth M
Pathologe; 2010 May; 31(3):177-81. PubMed ID: 20349063
[TBL] [Abstract][Full Text] [Related]
28. Gastric pyloric gland adenoma.
Pezhouh MK; Park JY
Arch Pathol Lab Med; 2015 Jun; 139(6):823-6. PubMed ID: 26030253
[TBL] [Abstract][Full Text] [Related]
29. Gastric adenocarcinoma of fundic gland mucosa type localized in the submucosa: A case report.
Uchida A; Ozawa M; Ueda Y; Murai Y; Nishimura Y; Ishimatsu H; Okouchi Y; Ishiguro K; Hamada Y; Sasamoto R; Watanabe M; Sano N; Miyamoto R; Inagawa S; Kikuchi K
Medicine (Baltimore); 2018 Sep; 97(37):e12341. PubMed ID: 30212986
[TBL] [Abstract][Full Text] [Related]
30. Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach.
Kushima R; Vieth M; Borchard F; Stolte M; Mukaisho K; Hattori T
Gastric Cancer; 2006; 9(3):177-84. PubMed ID: 16952035
[TBL] [Abstract][Full Text] [Related]
31. Gastric adenocarcinoma of fundic gland type (chief cell predominant type) treated with endoscopic aspiration mucosectomy.
Fukatsu H; Miyoshi H; Ishiki K; Tamura M; Yao T
Dig Endosc; 2011 Jul; 23(3):244-6. PubMed ID: 21699569
[TBL] [Abstract][Full Text] [Related]
32. Pyloric gland adenoma: a clinico-pathological analysis of 90 cases.
Vieth M; Kushima R; Borchard F; Stolte M
Virchows Arch; 2003 Apr; 442(4):317-21. PubMed ID: 12715167
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological characteristics of duodenal epithelial neoplasms: Focus on tumors with a gastric mucin phenotype (pyloric gland-type tumors).
Mitsuishi T; Hamatani S; Hirooka S; Fukasawa N; Aizawa D; Hara Y; Dobashi A; Goda K; Fukuda T; Saruta M; Urashima M; Ikegami M
PLoS One; 2017; 12(4):e0174985. PubMed ID: 28376132
[TBL] [Abstract][Full Text] [Related]
34. Pepsinogen I- and H+/K+-ATPase-immunohistochemical Positivity in Endoscopically Resected Early Gastric Neoplasia.
Hayasaka J; Inoshita N; Suzuki Y; Nomura K; Odagiri H; Ochiai Y; Tanaka M; Yamashita S; Matsui A; Kikuchi D; Kitagawa M; Hoteya S
Am J Surg Pathol; 2022 Apr; 46(4):443-453. PubMed ID: 34999591
[TBL] [Abstract][Full Text] [Related]
35. [A case of gastric-type adenoma with chief cell and parietal cell differentiation surrounded by complete intestinal metaplasia].
Furukawa R; Oyama T; Takahashi A; Yorimitsu N; Shimoda T; Ota H; Shiozawa S
Nihon Shokakibyo Gakkai Zasshi; 2017; 114(3):450-455. PubMed ID: 28260713
[TBL] [Abstract][Full Text] [Related]
36. Gastric adenocarcinoma of the fundic gland (chief cell predominant type) with brownish pigmentation.
Imagawa A; Sano N
Gastrointest Endosc; 2018 May; 87(5):1358-1359. PubMed ID: 29102736
[No Abstract] [Full Text] [Related]
37. RUNX3 expression correlates with chief cell differentiation in human gastric cancers.
Ogasawara N; Tsukamoto T; Mizoshita T; Inada KI; Ban H; Kondo S; Takasu S; Ushijima T; Ito K; Ito Y; Ichinose M; Ogawa T; Joh T; Tatematsu M
Histol Histopathol; 2009 Jan; 24(1):31-40. PubMed ID: 19012242
[TBL] [Abstract][Full Text] [Related]
38. Decreased expression of TFF2 and decreased αGlcNAc glycosylation are malignant biomarkers of pyloric gland adenoma of the duodenum.
Yamanoi K; Fujii C; Nakayama A; Matsuura N; Takatori Y; Kato M; Yahagi N; Nakayama J
Sci Rep; 2023 Dec; 13(1):21641. PubMed ID: 38062108
[TBL] [Abstract][Full Text] [Related]
39. [Endoscopic resection of a rare gastric adenoma (pyloric gland adenoma) with transition into a well-differentiated adenocarcinoma].
Dumoulin FL; Abel J; Zumfelde P; Hildenbrand R; Bollmann R
Z Gastroenterol; 2012 Apr; 50(4):393-5. PubMed ID: 22467542
[TBL] [Abstract][Full Text] [Related]
40. Gastric adenocarcinoma of the fundic gland (chief cell-predominant type): A review of endoscopic and clinicopathological features.
Miyazawa M; Matsuda M; Yano M; Hara Y; Arihara F; Horita Y; Matsuda K; Sakai A; Noda Y
World J Gastroenterol; 2016 Dec; 22(48):10523-10531. PubMed ID: 28082804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
